A. Colevas's Profile

Role	Title	Level	Year	L/R
🐜	CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. 11 auth. A. Trotti, A. Colevas, A. Setser, V. Rusch, D. Jaques, V. Budach, ... C. Langer, B. Murphy, R. Cumberlin, C. N. Coleman, P. Rubin	11	2003	11 🐜
🐜	Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. 23 auth. Robert L Ferris, G. Blumenschein, J. Fayette, J. Guigay, A. Colevas, L. Licitra, K. Harrington, S. Kasper, E. Vokes, C. Even, ... F. Worden, Nabil F. Saba, L. I. Docampo, R. Haddad, T. Rordorf, N. Kiyota, M. Tahara, M. Monga, M. Lynch, W. Geese, J. Kopit, James W. Shaw, Maura L Gillison	11	2016	11 🐜
🐜	Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. 29 auth. M. Posner, Diane M. Hershock, C. Blajman, E. Mickiewicz, E. Winquist, V. Gorbounova, S. Tjulandin, D. Shin, K. Cullen, Thomas J. Ervin, Barbara A. Murphy, Luis E. Raez, Roger B. Cohen, M. Spaulding, R. Tishler, ... B. Roth, Rosana del Carmen Viroglio, V. Venkatesan, I. Romanov, S. Agarwala, K. William Harter, M. Dugan, A. Cmelak, A. M. Markoe, Paul W. Read, L. Steinbrenner, A. Colevas, C. Norris, R. Haddad	10	2007	10 🐜
🐜	Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial 28 auth. M. Gillison, A. Trotti, J. Harris, A. Eisbruch, P. Harari, D. Adelstein, R. Jordan, Weiqiang Zhao, E. Sturgis, B. Burtness, J. Ridge, J. Ringash, J. Galvin, M. Yao, S. Koyfman, ... D. Blakaj, Mohammed A. Razaq, A. Colevas, J. Beitler, Christopher U. Jones, N. Dunlap, S. Seaward, S. Spencer, T. Galloway, J. Phan, J. Dignam, J. Dignam, Q. Le	9	2019	9 🐜
🐜	Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. 37 auth. D. Pfister, S. Spencer, D. Adelstein, D. Adkins, Y. Anzai, D. Brizel, J. Bruce, P. Busse, J. Caudell, A. Cmelak, A. Colevas, D. Eisele, M. Fenton, R. Foote, T. Galloway, ... M. Gillison, R. Haddad, W. Hicks, Y. Hitchcock, A. Jimeno, Debra S. Leizman, E. Maghami, L. Mell, B. Mittal, H. Pinto, J. Ridge, J. Rocco, C. Rodriguez, Jatin P. Shah, R. Weber, G. Weinstein, M. Witek, F. Worden, S. Yom, W. Zhen, J. Burns, S. Darlow	9	2020	9 🐜
🦁	NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. 35 auth. A. Colevas, S. Yom, D. Pfister, S. Spencer, D. Adelstein, D. Adkins, D. Brizel, B. Burtness, P. Busse, J. Caudell, A. Cmelak, D. Eisele, M. Fenton, R. Foote, J. Gilbert, ... M. Gillison, R. Haddad, W. Hicks, Y. Hitchcock, A. Jimeno, Debra S. Leizman, E. Maghami, L. Mell, B. Mittal, H. Pinto, J. A. Ridge, J. Rocco, C. Rodriguez, Jatin P. Shah, R. Weber, M. Witek, F. Worden, W. Zhen, J. Burns, S. Darlow	8	2018	8 🦁
🐜	NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. 37 auth. J. Caudell, M. Gillison, E. Maghami, S. Spencer, D. Pfister, D. Adkins, A. Birkeland, D. Brizel, P. Busse, A. Cmelak, A. Colevas, D. Eisele, T. Galloway, J. Geiger, R. Haddad, ... W. Hicks, Y. Hitchcock, A. Jimeno, Debra S. Leizman, L. Mell, B. Mittal, H. Pinto, J. Rocco, C. Rodriguez, P. Savvides, D. Schwartz, J. Shah, D. Sher, M. S. St John, R. Weber, G. Weinstein, F. Worden, Justine Yang Bruce, S. Yom, W. Zhen, J. Burns, S. Darlow	8	2022	8 🐜
🐜	Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia. 20 auth. J. Byrd, Thomas S. Lin, J. Dalton, Di Wu, M. Phelps, B. Fischer, M. Moran, K. Blum, B. Rovin, Michelle Brooker-McEldowney, ... Sarah Broering, L. Schaaf, A. Johnson, D. Lucas, N. Heerema, G. Lozanski, D. Young, J. Suárez, A. Colevas, M. Grever	8	2007	8 🐜
🐜	E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. 19 auth. S. Marur, Shuli Li, A. Cmelak, M. Gillison, Weiqiang Zhao, R. Ferris, H. William, Westra, J. Gilbert, J. Bauman, ... L. Wagner, D. Trevarthen, Jahagirdar Balkrishna, A. Barbara, Murphy, N. Agrawal, A. Colevas, C. Chung, B. Burtness	8	2017	8 🐜
🐜	First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers. 30 auth. B. Sikic, N. Lakhani, A. Patnaik, Sumit A Shah, S. Chandana, D. Rasco, A. Colevas, T. O'rourke, S. Narayanan, K. Papadopoulos, G. Fisher, V. Villalobos, Susan S. Prohaska, M. Howard, M. Beeram, ... M. Chao, B. Agoram, J. Chen, Jie Huang, M. Axt, Jie Liu, J. Volkmer, R. Majeti, I. Weissman, C. Takimoto, D. Supan, H. Wakelee, Rhonda Aoki, M. Pegram, S. Padda	8	2016	8 🐜
🐜	NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. 36 auth. D. Adelstein, M. Gillison, D. Pfister, S. Spencer, D. Adkins, D. Brizel, B. Burtness, P. Busse, J. Caudell, A. Cmelak, A. Colevas, D. Eisele, M. Fenton, R. Foote, J. Gilbert, ... R. Haddad, W. Hicks, Y. Hitchcock, A. Jimeno, Debra S. Leizman, W. Lydiatt, E. Maghami, L. Mell, B. Mittal, H. Pinto, J. A. Ridge, J. Rocco, C. Rodriguez, Jatin P. Shah, R. Weber, M. Witek, F. Worden, S. Yom, W. Zhen, J. Burns, S. Darlow	8	2017	8 🐜
🐜	Featured Updates to the NCCN Guidelines 34 auth. D. Pfister, K. Ang, David M. Brizel, B. Burtness, Paul M. Busse, Jimmy J Caudell, A. Cmelak, A. Colevas, Frank Dunphy, David W. Eisele, Jill Gilbert, Maura L Gillison, Robert I. Haddad, Bruce H. Haughey, Wesley L. Hicks, ... Ying J. Hitchcock, Merrill S. Kies, W. Lydiatt, E. Maghami, Renato Martins, Thomas V. McCaffrey, Bharat B. Mittal, Harlan A. Pinto, J. A. Ridge, Sandeep Samant, David E. Schuller, Jatin P. Shah, Sharon Spencer, Randall S. Weber, Gregory T. Wolf, F. Worden, S. Yom, Nicole R Mcmillian, Miranda Hughes	8	2013	8 🐜
🐜	Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma. 12 auth. L. Nabors, T. Mikkelsen, S. Rosenfeld, F. Hochberg, N. S. Akella, J. Fisher, ... G. Cloud, Y. Zhang, K. Carson, S. M. Wittemer, A. Colevas, S. Grossman	8	2007	8 🐜